A Dose Ranging Study of the Effect of Ruxolitinib Phosphate Cream When Applied to Participants With Plaque Psoriasis
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Monica Luchi, M.D.
Incyte Corporation
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
28 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Facility name not stated
Hot Springs, Arkansas, United States
- Facility name not stated
Los Angeles, California, United States
- Facility name not stated
San Diego, California, United States
- Facility name not stated
Santa Monica, California, United States
- Facility name not stated
Vallejo, California, United States
- Facility name not stated
New Haven, Connecticut, United States
- Facility name not stated
Miami, Florida, United States
- Facility name not stated
Ormond Beach, Florida, United States
- Facility name not stated
Naperville, Illinois, United States
- Facility name not stated
Wheaton, Illinois, United States
- Facility name not stated
Evansville, Indiana, United States
- Facility name not stated
South Bend, Indiana, United States
- Facility name not stated
Boston, Massachusetts, United States
- Facility name not stated
Clinton Township, Michigan, United States
- Facility name not stated
Fridley, Minnesota, United States
- Facility name not stated
St Louis, Missouri, United States
- Facility name not stated
Albuquerque, New Mexico, United States
- Facility name not stated
Rochester, New York, United States
- Facility name not stated
Norman, Oklahoma, United States
- Facility name not stated
Simpsonville, South Carolina, United States
- Facility name not stated
Austin, Texas, United States
- Facility name not stated
College Station, Texas, United States
- Facility name not stated
Dallas, Texas, United States
- Facility name not stated
Houston, Texas, United States
- Facility name not stated
Salt Lake City, Utah, United States
- Facility name not stated
Norfolk, Virginia, United States
- Facility name not stated
Walla Walla, Washington, United States
- Facility name not stated
Madison, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 28 Oct 2008
- Primary completion
- 26 Jun 2009
- Completion
- 26 Jun 2009
- Last update posted
- 9 Feb 2022
- Registered enrollment
- 199
- Registry id
- NCT00778700
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.